Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
HSRPP's Cash to Debt is ranked lower than
93% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. HSRPP: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
HSRPP' s Cash to Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: N/A
Current: 0.02
Equity to Asset 0.14
HSRPP's Equity to Asset is ranked lower than
88% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HSRPP: 0.14 )
Ranked among companies with meaningful Equity to Asset only.
HSRPP' s Equity to Asset Range Over the Past 10 Years
Min: -0.76  Med: -0.01 Max: 0.59
Current: 0.14
-0.76
0.59
Interest Coverage 3.77
HSRPP's Interest Coverage is ranked lower than
66% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 6.25 vs. HSRPP: 3.77 )
Ranked among companies with meaningful Interest Coverage only.
HSRPP' s Interest Coverage Range Over the Past 10 Years
Min: 0.29  Med: 2.92 Max: 4.8
Current: 3.77
0.29
4.8
F-Score: 3
Z-Score: 1.15
M-Score: -2.50
WACC vs ROIC
4.13%
12.30%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 17.89
HSRPP's Operating margin (%) is ranked higher than
84% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. HSRPP: 17.89 )
Ranked among companies with meaningful Operating margin (%) only.
HSRPP' s Operating margin (%) Range Over the Past 10 Years
Min: 3.97  Med: 18.41 Max: 22.19
Current: 17.89
3.97
22.19
Net-margin (%) 6.05
HSRPP's Net-margin (%) is ranked higher than
57% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 4.79 vs. HSRPP: 6.05 )
Ranked among companies with meaningful Net-margin (%) only.
HSRPP' s Net-margin (%) Range Over the Past 10 Years
Min: -36.52  Med: 9.88 Max: 48.3
Current: 6.05
-36.52
48.3
ROE (%) 33.27
HSRPP's ROE (%) is ranked higher than
93% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.90 vs. HSRPP: 33.27 )
Ranked among companies with meaningful ROE (%) only.
HSRPP' s ROE (%) Range Over the Past 10 Years
Min: 33.47  Med: 72.69 Max: 1149.06
Current: 33.27
33.47
1149.06
ROA (%) 4.84
HSRPP's ROA (%) is ranked higher than
55% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. HSRPP: 4.84 )
Ranked among companies with meaningful ROA (%) only.
HSRPP' s ROA (%) Range Over the Past 10 Years
Min: -17.98  Med: 8.44 Max: 44.36
Current: 4.84
-17.98
44.36
ROC (Joel Greenblatt) (%) 41.44
HSRPP's ROC (Joel Greenblatt) (%) is ranked higher than
73% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 17.56 vs. HSRPP: 41.44 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HSRPP' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -28.11  Med: 43.84 Max: 51.02
Current: 41.44
-28.11
51.02
Revenue Growth (3Y)(%) 16.00
HSRPP's Revenue Growth (3Y)(%) is ranked higher than
80% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. HSRPP: 16.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HSRPP' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -27  Med: -0.80 Max: 16
Current: 16
-27
16
EBITDA Growth (3Y)(%) 12.00
HSRPP's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. HSRPP: 12.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HSRPP' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -74.5  Med: 12.10 Max: 21.8
Current: 12
-74.5
21.8
EPS Growth (3Y)(%) 5.80
HSRPP's EPS Growth (3Y)(%) is ranked lower than
55% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. HSRPP: 5.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HSRPP' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -34.1  Med: 6.90 Max: 56
Current: 5.8
-34.1
56
» HSRPP's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HSRPP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1557.374.206 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 20.13
HSRPP's P/E(ttm) is ranked higher than
66% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. HSRPP: 20.13 )
Ranked among companies with meaningful P/E(ttm) only.
HSRPP' s P/E(ttm) Range Over the Past 10 Years
Min: 1.71  Med: 12.94 Max: 32.2
Current: 20.13
1.71
32.2
Forward P/E 15.65
HSRPP's Forward P/E is ranked higher than
58% of the 74 Companies
in the Global Medical Care industry.

( Industry Median: 16.81 vs. HSRPP: 15.65 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 20.03
HSRPP's PE(NRI) is ranked higher than
68% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. HSRPP: 20.03 )
Ranked among companies with meaningful PE(NRI) only.
HSRPP' s PE(NRI) Range Over the Past 10 Years
Min: 1.84  Med: 14.33 Max: 181.64
Current: 20.03
1.84
181.64
Price/Owner Earnings (ttm) 23.00
HSRPP's Price/Owner Earnings (ttm) is ranked higher than
57% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 26.24 vs. HSRPP: 23.00 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HSRPP' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 2.6  Med: 11.74 Max: 41.2
Current: 23
2.6
41.2
P/B 5.73
HSRPP's P/B is ranked lower than
83% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. HSRPP: 5.73 )
Ranked among companies with meaningful P/B only.
HSRPP' s P/B Range Over the Past 10 Years
Min: 4.58  Med: 8.35 Max: 189.01
Current: 5.73
4.58
189.01
P/S 1.35
HSRPP's P/S is ranked higher than
56% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.56 vs. HSRPP: 1.35 )
Ranked among companies with meaningful P/S only.
HSRPP' s P/S Range Over the Past 10 Years
Min: 0.39  Med: 1.16 Max: 3.94
Current: 1.35
0.39
3.94
PFCF 12.80
HSRPP's PFCF is ranked higher than
76% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 21.39 vs. HSRPP: 12.80 )
Ranked among companies with meaningful PFCF only.
HSRPP' s PFCF Range Over the Past 10 Years
Min: 1.76  Med: 9.95 Max: 18.1
Current: 12.8
1.76
18.1
POCF 8.66
HSRPP's POCF is ranked higher than
71% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.93 vs. HSRPP: 8.66 )
Ranked among companies with meaningful POCF only.
HSRPP' s POCF Range Over the Past 10 Years
Min: 1.53  Med: 6.76 Max: 23.61
Current: 8.66
1.53
23.61
EV-to-EBIT 13.02
HSRPP's EV-to-EBIT is ranked higher than
77% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 19.52 vs. HSRPP: 13.02 )
Ranked among companies with meaningful EV-to-EBIT only.
HSRPP' s EV-to-EBIT Range Over the Past 10 Years
Min: -189  Med: 10.50 Max: 39.6
Current: 13.02
-189
39.6
EV-to-EBITDA 10.34
HSRPP's EV-to-EBITDA is ranked higher than
70% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 13.44 vs. HSRPP: 10.34 )
Ranked among companies with meaningful EV-to-EBITDA only.
HSRPP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -157.5  Med: 9.05 Max: 1140.5
Current: 10.34
-157.5
1140.5
PEG 1.58
HSRPP's PEG is ranked higher than
67% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. HSRPP: 1.58 )
Ranked among companies with meaningful PEG only.
HSRPP' s PEG Range Over the Past 10 Years
Min: 1.05  Med: 1.52 Max: 2.18
Current: 1.58
1.05
2.18
Shiller P/E 19.51
HSRPP's Shiller P/E is ranked higher than
66% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 30.32 vs. HSRPP: 19.51 )
Ranked among companies with meaningful Shiller P/E only.
HSRPP' s Shiller P/E Range Over the Past 10 Years
Min: 14.65  Med: 25.76 Max: 330.5
Current: 19.51
14.65
330.5
Current Ratio 1.40
HSRPP's Current Ratio is ranked higher than
53% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.36 vs. HSRPP: 1.40 )
Ranked among companies with meaningful Current Ratio only.
HSRPP' s Current Ratio Range Over the Past 10 Years
Min: 0.66  Med: 1.15 Max: 2.76
Current: 1.4
0.66
2.76
Quick Ratio 1.40
HSRPP's Quick Ratio is ranked higher than
58% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. HSRPP: 1.40 )
Ranked among companies with meaningful Quick Ratio only.
HSRPP' s Quick Ratio Range Over the Past 10 Years
Min: 0.66  Med: 1.15 Max: 2.61
Current: 1.4
0.66
2.61
Days Sales Outstanding 48.06
HSRPP's Days Sales Outstanding is ranked lower than
56% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 44.25 vs. HSRPP: 48.06 )
Ranked among companies with meaningful Days Sales Outstanding only.
HSRPP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.54  Med: 44.92 Max: 49.69
Current: 48.06
40.54
49.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 4.20
HSRPP's Dividend Yield is ranked higher than
53% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 2.09 vs. HSRPP: 4.20 )
Ranked among companies with meaningful Dividend Yield only.
HSRPP' s Dividend Yield Range Over the Past 10 Years
Min: 0.5  Med: 1.87 Max: 2.83
Current: 4.2
0.5
2.83
Yield on cost (5-Year) 4.20
HSRPP's Yield on cost (5-Year) is ranked lower than
56% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 2.74 vs. HSRPP: 4.20 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HSRPP' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.5  Med: 1.87 Max: 2.83
Current: 4.2
0.5
2.83
3-Year Average Share Buyback Ratio 2.20
HSRPP's 3-Year Average Share Buyback Ratio is ranked higher than
91% of the 129 Companies
in the Global Medical Care industry.

( Industry Median: -2.80 vs. HSRPP: 2.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HSRPP' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.3  Med: -1.60 Max: 2.7
Current: 2.2
-8.3
2.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.96
HSRPP's Price/Projected FCF is ranked higher than
80% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. HSRPP: 0.96 )
Ranked among companies with meaningful Price/Projected FCF only.
HSRPP' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.81  Med: 1.21 Max: 208.64
Current: 0.96
0.81
208.64
Price/Median PS Value 1.17
HSRPP's Price/Median PS Value is ranked lower than
59% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. HSRPP: 1.17 )
Ranked among companies with meaningful Price/Median PS Value only.
HSRPP' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.42  Med: 1.00 Max: 2.61
Current: 1.17
0.42
2.61
Price/Peter Lynch Fair Value 1.64
HSRPP's Price/Peter Lynch Fair Value is ranked higher than
64% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 2.21 vs. HSRPP: 1.64 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HSRPP' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.48  Med: 1.38 Max: 2.35
Current: 1.64
0.48
2.35
Earnings Yield (Greenblatt) (%) 7.70
HSRPP's Earnings Yield (Greenblatt) (%) is ranked higher than
82% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. HSRPP: 7.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HSRPP' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.5  Med: 8.40 Max: 15.8
Current: 7.7
2.5
15.8
Forward Rate of Return (Yacktman) (%) 19.31
HSRPP's Forward Rate of Return (Yacktman) (%) is ranked higher than
76% of the 102 Companies
in the Global Medical Care industry.

( Industry Median: 11.10 vs. HSRPP: 19.31 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HSRPP' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -16.6  Med: 12.20 Max: 26.7
Current: 19.31
-16.6
26.7

More Statistics

Short Percentage of Float0.00%
52-Week Range $1265.00 - 1605.84

Business Description

Industry: Health Care Providers » Medical Care
Compare:JSE:NTC, NAS:LPNT, LSE:NMC, NYSE:THC, BOM:508869 » details
Traded in other countries:HSOA.Germany, HLS.USA,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.
» More Articles for HSRPP

Headlines

Articles On GuruFocus.com
Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
26.25% Annual Return With Lobbying Stocks? Here Is How It Works Nov 21 2014 
5 Stocks Building Long-Term Wealth With Increased Dividends Jul 28 2014 
"Thrift, fearlessness, resilience, hard work" - What Makes Mariko Gordon Our Newest Guru Dec 07 2013 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
HEALTHSOUTH Corp. Reports Operating Results (10-K) Feb 24 2011 
Weekly CEO Buys Highlight: City National Corp, Thomas Properties Group Inc, Juniper Networks Inc, He Nov 16 2008 

More From Other Websites
Analyst: HealthSouth Back on Track After 'Un-HealthSouth-Like' 2015 Apr 27 2016
HealthSouth beats Street 1Q forecasts Apr 26 2016
HealthSouth beats Street 1Q forecasts Apr 26 2016
New hospital opens, another announced for growing 'burb Mar 29 2016
$17M hospital opens in Norwood Mar 11 2016
HealthSouth (HLS) Stock Rises Following Quarterly Results Feb 24 2016
Healthsouth (HLS) Meets Q4 Earnings Estimates, Raises 2016 Outlook Feb 23 2016
HealthSouth tops Wall Street estimates, raises outlook Feb 23 2016
HealthSouth meets 4Q profit forecasts Feb 23 2016
HealthSouth meets 4Q profit forecasts Feb 23 2016
Healthsouth Is Rehabilitated and Ready to Run Feb 01 2016
Birmingham weighs $1.9M in incentives for HealthSouth HQ Jan 25 2016
Throwback Thursday: When Liberty Park was in the running for a zoo, a theme park and a big HQ Jan 21 2016
Real Estate Roundup: Local firms end year strong Dec 31 2015
HealthSouth relocating HQ to new building at Liberty Park Dec 04 2015
Clovis Oncology Inc (CLVS): Are Hedge Funds Right About This Stock? Dec 01 2015
Is HEALTHSOUTH Corp. (HLS) A Good Stock To Buy? Nov 26 2015
Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015
Why Are These Five Stocks Falling on Thursday? Oct 29 2015
Revenues continue to climb for HealthSouth in 3Q Oct 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK